SCIENTIFIC BACKGROUND

DZIP1L, PKHD1

Scientific Background

Autosomal recessive polycystic kidney disease (ARPKD) is a rare form of polycystic kidney disease that originates primarily from the collecting duct. It occurs in about 1:20,000 live births. The classic ARPKD phenotype is characterized by an early onset of disease with bilateral renal enlargement and impairment of renal function, congenital liver fibrosis with development of portal hypertension, and dilatation of the bile ducts with the risk of ascending cholangitis. In about 15-37% of the described ARPKD patients, gastrointestinal varices are detected. ARPKD is typically seen in utero or at birth and in the most severe cases includes the Potter sequence, low amniotic fluid levels, pulmonary hypoplasia and bilaterally enlarged echogenic kidneys. While kidney involvement typically occurs early in childhood, liver involvement tends to appear later. ARPKD is generally associated with a shortened life expectancy. A mortality rate of 30‑40% has been described in cases of neonatal respiratory difficulties, and about 50% of patients who survive the neonatal period develop terminal renal failure within the first decade of life. Despite the classic neonatal presentation of ARPKD, there is a significant variability in age at onset and clinical symptoms, including within a family.

 

The most frequent molecular cause is pathogenic variants in the PKHD1 gene. The heterozygote frequency in the Caucasian population is about 1:70. Therefore, a heterozygous PKHD1 variant is a relatively common random finding and does not necessarily mean an undetected variant on the second allele in an affected patient. No causative PKHD1 variants are identified by sequencing in 13-20% of cases. Genomic deletions or duplications are rarely detectable. In rare cases, causal changes in the DZIP1L gene can be found. Variants in numerous other genes, often from the group of ciliopathies, can also cause an ARPKD-like genotype. In addition, there are very early manifesting forms of autosomal dominant PKD or HNF1B-associated nephropathies that are also known as "phenocopies" (diseases with other molecular genetic causes with similar phenotype).

 

References

Brugmaier et al. 2019, Sci Rep 9:7919 / Szabó et al. 2018, Pediatr Nephrol 33:1713 / Haumann et al. 2018, medgen 30:422 / Melchionda et al. 2016, J Hum Genet 61:811 / Zvereff et al. 2010, Genet Test Mol Biomarkers 14:505 / Gunay-Aygun et al. 2010, Clin J Am Soc Nephrol 5:972 / Michel-Calemard et al. 2009, Clin Genet 75:203 / Harris and Torres 2009, Annu Rev Med 60:321

GENES

DZIP1L, PKHD1

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled ...

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more